查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466234

呼吸诊断市场：按产品类型、适应症和最终用户划分 - 全球预测 2024-2030

Respiratory Diagnostics Market by Product (Assays & Reagents, Instruments & Devices, Software & Services), Test Type (Imaging Tests, Mechanical Tests, Molecular Diagnostic Tests), Indication, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

呼吸诊断市场规模预计2023年为61.2亿美元，2024年达到66.6亿美元，预计2030年将达到109.6亿美元，复合年增长率为8.67%。

呼吸诊断是医疗保健产业的重要组成部分，专注于识别、监测和治疗呼吸系统疾病，包括气喘、慢性阻塞性肺病(COPD)、肺部肿瘤、结核病、肺炎等。呼吸诊断测试包括影像检查、肺活量测定、尖峰流量测试、血液气体测试、肺功能测试和多种其他诊断技术。由于空气污染水平上升、吸烟、遗传倾向和职业危害，呼吸系统疾病的盛行率不断增加，因此需要使用呼吸系统诊断解决方案。然而，报销和保险政策的不足，以及与复杂诊断程序相关的错误风险，也可能阻碍呼吸诊断的普及。此外，先进的诊断系统需要训练有素的专业人员来操作，这给市场扩张带来了挑战。然而，政府努力加强医疗基础设施和呼吸健康解决方案的获取，以及增加对研发活动的投资，可能有助于克服呼吸诊断解决方案所面临的财务和技术限制。携带式监测设备、先进的分子诊断测试和数数位化进步等创新将远端医疗服务纳入呼吸照护领域，提供了新的成长领域。

主要市场统计
基准年[2023] 61.2亿美元
预测年份 [2024] 66.6亿美元
预测年份 [2030] 109.6亿美元
复合年增长率（%） 8.67%

产品病原体的快速检测需求推动了检测方法和试剂的采用

呼吸诊断设备和装置专门设计用于执行各种测试，以帮助识别肺部和呼吸系统疾病。这包括肺计量计、雾化器、峰值流量计、示波器、睡眠多项生理检查、气体分析仪、睡眠测试设备等。呼吸诊断中使用的试剂包括缓衝溶液、对照溶液、校正溶液、核苷酸、DNA聚合酵素等酵素、引子、探针、染料和用于样品製备的反应溶液。逆转录聚合酵素链锁反应(RT-PCR)、酵素结合免疫吸附检测法(ELISA) 和快速诊断测试 (RDT) 等检测方法经常用于检测与呼吸道病原体相关的抗体和抗原。软体和服务在管理患者健康记录、分析资料和促进不同医疗机构之间的连接方面发挥着至关重要的作用。电子健康记录(EHR) 和医院资讯系统 (HIS) 等软体解决方案和服务可提供简化的资料管理和诊断结果的高效通讯。服务包括专家咨询、设备安装、使用者培训和定期诊断设备维护。

提高分子诊断测试准确性和特异性的测试类型研究计划

影像检查在观察呼吸系统结构、帮助诊断异常和监测疾病进展方面发挥重要作用。电脑断层扫描 (CT) 等影像检查可提供更详细的肺部截面视图，并突出显示结节、肿瘤和复杂的肺部疾病。另一方面，磁振造影(MRI) 可用于胸壁、纵隔以及有时软组织异常的详细成像。机械测试评估肺部的物理功能。肺功能测试（PFT）测量肺活量、肺活量、流速和气体交换，肺活量测定法透过测量可吸入和呼出的空气的速度和量来评估肺功能。分子诊断在分子层面分析生物标誌物，提供有关遗传倾向、传染源和疾病特异性特征的信息，并实现精准医疗。聚合酵素链锁反应(PCR) 用于检测细菌和病毒病原体以及呼吸道疾病感染的存在。阻塞型睡眠呼吸中止症(OSA) 测试对于评估睡眠期间呼吸浅或停止的时期至关重要。传统的呼吸系统诊断包括基本的实验室测试，例如显微镜检查和生物化学检验。由于其成本低、快速、程序简单且特异性高，显微镜仍是检测结核病病例的重要诊断工具。

需要先进的呼吸诊断技术来实现适应性慢性阻塞性肺病的准确检测

气喘是一种慢性疾病，其特征是由于呼吸道频繁发生潜在发炎而导致呼吸困难。气喘的呼吸诊断策略通常包括肺功能测试，例如肺活量测定，以评估气道阻塞的程度和可逆性。此外，呼出一氧化氮 (FeNO) 的测量间接反映气道发炎并提供进一步的诊断见解。慢性阻塞性肺病（COPD）是一种导致呼吸困难的进行性肺部疾病，其特征是慢性支气管炎和肺气肿。 COPD 的呼吸诊断药物包括测量肺功能的肺活量测试、观察肺部的胸部 X 光检查和 CT 测试，以及确定肺部向血液输送多少氧气以及清除多少二氧化碳的测试。 。肺癌是一种严重且致命的疾病，通常始于支气管和细支气管内壁的细胞。诊断通常涉及影像检查，例如胸部 X 光检查或电脑断层扫描。肺炎是感染疾病一个或两个肺部气囊发炎的感染。此疾病通常透过身体检查来诊断，然后进行胸部 X 光检查以确认感染并确定其位置和程度。此外，痰液和血液检查可以帮助确定引起感染的微生物类型并确定最有效的治疗方法。结核病可能是一种主要影响肺部的严重感染疾病。结核病的呼吸诊断涉及两项主要检查：皮肤试验（可识别结核病暴露）和干扰素-γ释放测定（可确认活动性或潜伏性感染）。胸部 X 光检查和电脑断层扫描用于进一步评估肺部损伤，痰液检测可揭示结核菌是否具有抗药性并有助于制定治疗计划。

最终使用者：在医院和诊所采用多种诊断工具来识别和监测呼吸道疾病

诊断实验室是呼吸诊断最终用途的关键组成部分。这些机构始终致力于检测和诊断各种呼吸系统疾病，例如慢性阻塞性肺病（COPD）、气喘、结核病和肺炎。配备高度先进和复杂的测试设备的诊断实验室可提供准确可靠的结果，这是病人历程获得适当治疗和康復过程中的重要里程碑。医院在医疗保健服务中发挥关键作用，并配备了尖端的呼吸诊断工具来识别呼吸系统疾病。其使用范围从门诊到加护病房，为广大患者提供准确、及时的诊断。研究机构在呼吸诊断领域中发挥着至关重要的作用。这些实验室对于评估现有诊断工具的有效性和开发下一代呼吸诊断解决方案至关重要。这些机构正在促进对诊断方法的广泛研究，这些方法可以在早期阶段识别疾病，以提高生存率并儘量减少对患者生活品质的影响。

区域洞察

美洲在全球呼吸诊断市场中占有重要地位。呼吸系统疾病的高发生率、意识的提高以及积极的医疗干预措施正在推动美洲对先进呼吸系统诊断的需求。该国先进的医疗基础设施也促进了高品质诊断设备的生产。对诊断服务不断增长的需求以及快速发展的医疗基础设施正在支持亚洲呼吸诊断设备的生产。呼吸系统疾病的流行以及国内外主要市场参与者的扩张正在推动该地区的市场开拓。欧洲呼吸诊断市场受到大量创新呼吸诊断测试和已建立的医疗保健系统的显着影响。欧盟 (EU) 制定的监管指南也为呼吸诊断设备製造过程中严格的品管铺平了道路。中东和非洲呼吸系统疾病的盛行率不断上升，需要先进诊断解决方案的稳定供应。该地区呼吸诊断设备的生产有限，因为当地製造商很少。然而，多家国际公司正专注于在该地区製造呼吸诊断设备并站稳脚跟。

FPNV定位矩阵

FPNV 定位矩阵对于评估呼吸诊断市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对呼吸诊断市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.呼吸诊断市场的市场规模与预测是多少？

2.呼吸诊断市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.呼吸诊断市场的技术趋势和法规结构是什么？

4.呼吸诊断市场主要厂商的市场占有率为何？

5.进入呼吸诊断市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧，更容易罹患慢性呼吸道疾病
      • 呼吸系统疾病诊断套件、测试和系统的核准增加
      • 远端和居家照护测试设备越来越受欢迎
    • 抑制因素
      • 具有报销限制的呼吸诊断面板和套件的案例
    • 机会
      • 科技进步引进先进的呼吸诊断工具
      • 政府对呼吸诊断工具的承诺与资助
    • 任务
      • 与复杂诊断程序相关的错误风险
  • 市场区隔分析
    • 产品：快速检测病原体的需求推动了测试和试剂的采用
    • 测试类型：提高分子诊断测试准确性和特异性的研究倡议
    • 适应症：需要先进的呼吸诊断技术来实现慢性阻塞性肺病的准确检测
    • 最终使用者：在医院和诊所采用多种诊断工具来识别和监测呼吸道疾病
  • 市场趋势分析
    • 美洲地区医疗保健基础设施和支持性监管环境的投资可能会推动市场的显着成长。
    • 亚太地区非常需要早期检测和呼吸道诊断解决方案，以监测和管理病毒性呼吸道感染疾病。
    • 欧洲、中东和非洲地区成熟的呼吸诊断开发为政府和私人疾病筛检工作提供了先进的测试能力。
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章呼吸诊断市场：副产品

  • 测定和试剂
  • 设备和装置
  • 软体和服务

第七章按测试类型分類的呼吸诊断市场

  • 影像检查
  • 机械测试
  • 分子诊断测试
  • OSA 诊断测试
  • 传统诊断测试

第八章以适应症分類的呼吸诊断市场

  • 气喘
  • 慢性阻塞性肺病
  • 肺癌
  • 肺炎
  • 结核

第九章呼吸诊断市场：依最终用户分类

  • 诊断实验室
  • 医院/诊所
  • 调查机构

第十章北美和南美呼吸诊断市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太呼吸诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲呼吸诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 纽约大学 Langone Health 与飞利浦建立为期 8 年的合作伙伴关係
    • Masimo 的 ORi 获得新核准
    • 生物梅里埃向 FDA 提交 BIOFIRE SPOTFIRE 呼吸/威胁 (R/ST) 面板的双重 510(k) 和 CLIA 豁免申请
    • BD 获得 510(k)核准COVID-19、甲型/乙型流感和呼吸道融合病毒（RSV）分子联合测试
    • 瑞思迈收购睡眠和呼吸诊断软体製造商 Somnoware
    • Seagen 的 30 项诊断测试获得 IVDR 认证
    • Hologic 宣布 FDA核准Panther Fusion SARS-CoV-2/流感 A/B/RSV 检测
    • QIAGEN 在日本推出配备呼吸面板的 QIAstat-Dx，用于综合征测试
    • Thermo Fisher 与 ALPCO-GeneProof 合作扩大 CE-IVD 分子检测产品组合
    • Molbio Diagnostics 将 Truenat H3N2/H1N1 检测加入呼吸道疾病产品组合中
    • Vitalograph推出新型呼吸设备VitaloPFT系列
    • SD Biosensors 和 SJL Partners 完成 Meridian Bioscience 收购交易
    • 飞利浦和 Masimo 扩大合作伙伴关係，为世界各地的患者和医生改善远端医疗

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-894699F5EBCB

[194 Pages Report] The Respiratory Diagnostics Market size was estimated at USD 6.12 billion in 2023 and expected to reach USD 6.66 billion in 2024, at a CAGR 8.67% to reach USD 10.96 billion by 2030.

Respiratory diagnostics is a vital component of the healthcare industry, focusing on the identification, monitoring, and treatment of respiratory diseases, which include asthma, chronic obstructive pulmonary disease (COPD), lung tumors, tuberculosis, and pneumonia, among others. Respiratory diagnostics testing methods encompass the use of imaging tests, spirometry, peak flow tests, blood gas tests, pulmonary function tests, and multiple other diagnostic techniques. Escalation in the prevalence of such respiratory conditions due to rising air pollution levels, smoking, genetic predispositions, and occupational hazards has necessitated the use of respiratory diagnostics solutions. However, inadequate reimbursement and insurance policies and the risk of errors associated with complex diagnostic procedures could also impede the proliferation of respiratory diagnostics. Moreover, the need for trained professionals to operate advanced diagnostic systems presents a challenge to the market's expansion. However, government initiatives aimed at enhancing health infrastructure and access to respiratory health solutions and increasing investments in research and development activities can help overcome the financial and technical limitations of respiratory diagnostics solutions. Innovations such as portable monitoring devices, advanced molecular diagnostic tests, and increased digitalization leading to the incorporation of telehealth services in respiratory care offer new areas for growth.

KEY MARKET STATISTICS
Base Year [2023] USD 6.12 billion
Estimated Year [2024] USD 6.66 billion
Forecast Year [2030] USD 10.96 billion
CAGR (%) 8.67%

Product: Need for rapid detection of pathogens driving the adoption of assays and reagents

Respiratory diagnostic instruments and devices are specifically designed to perform various tests that help identify lung and respiratory disorders. These include spirometers, nebulizers, peak flow meters, oscillometers, polysomnographs, gas analyzers, and sleep test devices. Reagents employed in respiratory diagnostics include buffers, control solutions, calibration solutions, nucleotides, enzymes such as DNA polymerases, primers, probes, dyes, and reactants for sample preparation. Assays, including the reverse transcriptase polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), and rapid diagnostic tests (RDTs), are frequently utilized for the detection of antibodies or antigens related to respiratory pathogens. Software and services play a pivotal role in managing patient health records, data analysis, and facilitating connections between different healthcare entities. Software solutions and services, such as electronic health records (EHRs) and hospital information systems (HIS), offer streamlined data management and efficient diagnostic results communication. Services include professional consultation, device implementation, user training, and regular diagnostics device maintenance.

Test Type: Research initiatives to advance the accuracy and specificity of molecular diagnostic tests

Imaging tests play a critical role in visualizing the structure of the respiratory system, aiding in the diagnosis of abnormalities, and monitoring disease progression. Imaging tests such as computed tomography (CT) provide a more detailed cross-sectional view of the lungs, highlighting nodules, tumors, and complex lung diseases, while magnetic resonance imaging (MRI) is useful in detailed imaging of the chest wall, mediastinum, and occasionally soft tissue abnormalities. Mechanical tests evaluate the physical function of the lungs. Pulmonary function tests (PFTs) measure lung volume, capacity, rates of flow, and gas exchange, while spirometry assesses how well the lungs function by measuring the speed and volume of air that can be inhaled or exhaled. Molecular diagnostics involve analyzing biomarkers at the molecular level, providing information on genetic predispositions, infectious pathogens, and specific characteristics of diseases, enabling precision medicine. Polymerase chain reaction (PCR) is used to detect the presence of bacterial and viral pathogens or infections in respiratory illnesses. Obstructive sleep apnea (OSA) tests are vital in assessing periods of shallow or paused breathing during sleep. Traditional respiratory diagnostics involve basic laboratory tests, such as microscopy and biochemical tests. For tuberculosis case detection, microscopy continues to be an indispensable diagnostics tool, given its low cost, rapidity, simplicity of procedure, and high specificity.

Indication: Need for advanced respiratory diagnostic technologies to attain accurate testing of chronic obstructive pulmonary disease

Asthma is a chronic condition characterized by difficulty in breathing due to frequent, underlying inflammation of the airways. Respiratory diagnostic strategies for asthma usually involve pulmonary function tests, such as spirometry, which assess the extent of airway obstruction and reversibility. Moreover, the measurement of fractional exhaled nitric oxide (FeNO) indirectly reflects airway inflammation, providing further diagnostic insight. Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that causes breathing difficulties and features chronic bronchitis and emphysema. Respiratory diagnostics for COPD involve a range of tests, including the spirometry test to measure lung function, a chest X-ray or CT scan to view the lungs, and arterial blood gas analysis to measure how well the lungs are transferring oxygen to the bloodstream and removing carbon dioxide. Lung cancer, a serious and potentially fatal disease, often originates in the cells lining the bronchi or bronchioles. Diagnosis typically includes imaging tests such as chest X-rays and CT scans for initial detection. Pneumonia is an infection that inflames the air sacs in one or both lungs. The disease is typically diagnosed through physical examinations, followed by a chest X-ray, which can confirm the infection and determine its location and extent. Additionally, sputum tests and blood tests can be utilized to identify the type of microorganism causing the infection, helping to determine the most effective treatment approach. Tuberculosis is a potentially severe infectious disease affecting primarily the lungs. Two main tests are used in respiratory diagnostics for TB: the skin test, which identifies TB exposure, and the interferon-gamma release assay, which can confirm active or latent infection. A chest X-ray or CT scan may be used to assess lung damage further, while a sputum test can reveal if the strain of TB is drug-resistant, assisting in treatment planning.

End-User: Adoption of a diverse range of diagnostic tools in hospitals and clinics for identifying and monitoring respiratory ailments

Diagnostic laboratories form a critical component of the end-use landscape for respiratory diagnostics. These entities are consistently involved in testing and diagnosis of various respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. With their highly advanced and complex set of testing equipment, diagnostic laboratories offer accurate and reliable results, serving as a key milestone in the patient's journey toward appropriate treatment and recovery. Hospitals, given their primary role in healthcare delivery, are equipped with state-of-the-art respiratory diagnostics tools for identifying respiratory diseases. Their usage extends from outpatient departments to intensive care units, bringing precise and timely diagnostics to the broadest set of patients. Research institutes play an indispensable role in the field of respiratory diagnostics. These institutions are vital in both evaluating the efficacy of existing diagnostic tools and developing the next generation of respiratory diagnostic solutions. They facilitate extensive research into diagnostic methods that can identify diseases at an earlier stage to increase the survival rate and minimize the impact on patient's quality of life.

Regional Insights

The Americas pose a significant position in the global market for respiratory diagnostics. High incidences of respiratory diseases coupled with heightened awareness and proactive medical interventions contribute to the need for advanced respiratory diagnostics in the Americas. The availability of sophisticated healthcare infrastructure also facilitates the production of high-quality diagnostic equipment. The escalating demand for diagnostic services and the presence of rapidly developing healthcare infrastructure support the production of respiratory diagnostic devices in Asia. The prevalence of respiratory diseases and the expansion of key market players, both domestic and international,, have elevated market development in the region. Europe's market for respiratory diagnostics is heavily influenced by the high availability of innovative respiratory diagnostic tests and the presence of well-established healthcare systems. Regulatory guidelines laid down by the European Union also pave the way for stringent quality control during the production of respiratory diagnostic devices. Middle East & Africa also observes an increasing prevalence of respiratory diseases, creating a need for consistent availability of advanced diagnosis solutions. The production of respiratory diagnostic devices is limited in the region due to a lack of local manufacturers. However, various international companies are focusing on and have expanded their foothold in this region for respiratory diagnostic device manufacturing.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Respiratory Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Respiratory Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaltis S.r.l., Altona Diagnostics GmbH, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Bioneer Corporation, CerTest Biotec S.L., Daan Gene Co., Ltd., Diatech Pharmacogenetics srl, Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Hologic, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic PLC, Merck KGaA, ProAxsis by NetScientific PLC, Quest Diagnostics Incorporated, Quidel Corporation, Sansure Biotech Inc., SDI Diagnostics, Inc., Seegene Inc., Siemens Healthineers AG, Somnoware by ResMed Corp., Thermo Fisher Scientific Inc., Vitalograph Ltd., and ZeptoMetrix LLC.

Market Segmentation & Coverage

This research report categorizes the Respiratory Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Assays & Reagents
    • Instruments & Devices
    • Software & Services
  • Test Type
    • Imaging Tests
      • Computed Tomography
      • Magnetic Resonance Imaging
      • Positron Emission Tomography
      • X-Ray
    • Mechanical Tests
      • Peak Flow Test
      • Pulmonary Function Tests
      • Spirometry
    • Molecular Diagnostic Tests
      • DNA Sequencing & Next-Generation Sequencing
      • In Situ Hybridization
      • Microarrays
      • Nucleic Acid Amplification Test
      • PCR
    • OSA Diagnostic Tests
    • Traditional Diagnostic Tests
      • Biochemical Tests
      • Immunodiagnostics
      • Microscopy
  • Indication
    • Asthma
    • Chronic Obstructive Pulmonary Disease
    • Lung Cancer
    • Pneumonia
    • Tuberculosis
  • End-User
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Respiratory Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Respiratory Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Respiratory Diagnostics Market?

4. What is the market share of the leading vendors in the Respiratory Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Respiratory Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing aging population with susceptibility to chronic respiratory diseases
      • 5.1.1.2. Growth in the approvals for respiratory disease diagnostic kits, tests, and systems
      • 5.1.1.3. Rising preferences for remote and home care testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall of respiratory diagnosis panels and kits with limited reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements to introduce sophisticated respiratory diagnostic tools
      • 5.1.3.2. Government initiatives and funding for respiratory diagnostic tools
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of errors associated with complex diagnostic procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Need for rapid detection of pathogens driving the adoption of assays and reagents
    • 5.2.2. Test Type: Research initiatives to advance the accuracy and specificity of molecular diagnostic tests
    • 5.2.3. Indication: Need for advanced respiratory diagnostic technologies to attain accurate testing of chronic obstructive pulmonary disease
    • 5.2.4. End-User: Adoption of a diverse range of diagnostic tools in hospitals and clinics for identifying and monitoring respiratory ailments
  • 5.3. Market Trend Analysis
    • 5.3.1. Significant market growth potential driven by investments in healthcare infrastructure and supportive regulatory landscape in the Americas region
    • 5.3.2. Massive need of early detection and respiratory diagnostic solutions to monitor and manage viral respiratory infections in APAC
    • 5.3.3. Well-established respiratory diagnostics development across EMEA enabling the provision of advanced testing capabilities for government and private disease screening activities
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Respiratory Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Assays & Reagents
  • 6.3. Instruments & Devices
  • 6.4. Software & Services

7. Respiratory Diagnostics Market, by Test Type

  • 7.1. Introduction
  • 7.2. Imaging Tests
  • 7.3. Mechanical Tests
  • 7.4. Molecular Diagnostic Tests
  • 7.5. OSA Diagnostic Tests
  • 7.6. Traditional Diagnostic Tests

8. Respiratory Diagnostics Market, by Indication

  • 8.1. Introduction
  • 8.2. Asthma
  • 8.3. Chronic Obstructive Pulmonary Disease
  • 8.4. Lung Cancer
  • 8.5. Pneumonia
  • 8.6. Tuberculosis

9. Respiratory Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals & Clinics
  • 9.4. Research Institutes

10. Americas Respiratory Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Respiratory Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Respiratory Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. NYU Langone Health Enters 8-Year Partnership with Philips
    • 13.3.2. Masimo Gets De Novo Approval From FDA for ORi
    • 13.3.3. bioMerieux Submits Dual 510(k) and CLIA-Waiver Application to FDA for the BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel
    • 13.3.4. BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
    • 13.3.5. ResMed Acquires Sleep and Respiratory Diagnostics Software Maker Somnoware
    • 13.3.6. Seegene Obtains IVDR Certification for 30 Diagnostic Assays
    • 13.3.7. Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
    • 13.3.8. QIAGEN Launches QIAstat-Dx in Japan with Respiratory Panel for Syndromic Testing
    • 13.3.9. Thermo Fisher partners with ALPCO-GeneProof to Broaden Their CE-IVD Molecular Assay Portfolio
    • 13.3.10. Molbio Diagnostics adds Truenat H3N2/H1N1 Test to Respiratory Disease Portfolio
    • 13.3.11. Vitalograph Launches New Respiratory VitaloPFT Series
    • 13.3.12. SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience
    • 13.3.13. Philips and Masimo Expand Partnership To Improve Telehealth For Patients And Clinicians Around The World

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RESPIRATORY DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. RESPIRATORY DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RESPIRATORY DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. RESPIRATORY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. RESPIRATORY DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESPIRATORY DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASSAYS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY X-RAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEAK FLOW TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PEAK FLOW TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PULMONARY FUNCTION TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY SPIROMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DNA SEQUENCING & NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OSA DIAGNOSTIC TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY OSA DIAGNOSTIC TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY BIOCHEMICAL TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY ASTHMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PNEUMONIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 95. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 96. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 97. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 102. AMERICAS RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 111. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 112. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 113. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 114. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 115. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ARGENTINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 127. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 128. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 129. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 130. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 131. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. BRAZIL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 140. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 143. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 144. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 145. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 146. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 147. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. CANADA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 156. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 157. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 158. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 159. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 160. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 161. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 162. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 163. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. MEXICO RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 172. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 173. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 174. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 175. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 176. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 177. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 178. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 179. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED STATES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC RESPIRATORY DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 203. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 208. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 210. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 212. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 214. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. AUSTRALIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 224. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 225. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 226. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 227. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 228. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 229. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 230. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 231. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. CHINA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 240. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 241. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 242. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 243. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 244. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 245. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 246. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 247. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. INDIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 256. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 257. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 258. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 259. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 260. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 261. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 262. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 263. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. INDONESIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 272. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 273. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 274. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 275. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 276. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 277. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 278. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 279. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. JAPAN RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 288. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 289. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 290. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 291. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 292. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 293. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 294. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 295. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. MALAYSIA RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 304. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)
  • TABLE 306. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2024-2030 (USD MILLION)
  • TABLE 307. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 308. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 309. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2018-2023 (USD MILLION)
  • TABLE 310. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TRADITIONAL DIAGNOSTIC TESTS, 2024-2030 (USD MILLION)
  • TABLE 311. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 312. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 313. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 314. PHILIPPINES RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 315. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
  • TABLE 318. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
  • TABLE 319. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2018-2023 (USD MILLION)
  • TABLE 320. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY IMAGING TESTS, 2024-2030 (USD MILLION)
  • TABLE 321. SINGAPORE RESPIRATORY DIAGNOSTICS MARKET SIZE, BY MECHANICAL TESTS, 2018-2023 (USD MILLION)